All In MedTech

Device Trial Radar · NCT02483988

The SUN Clinical Trial (Safety Utilizing NUsurface Meniscus Implant)

The SUN Clinical Trial (Safety Utilizing NUsurface Meniscus Implant). A Multi-center, Single-arm, Prospective, Open-label, Non-randomized, Observational Clinical Study

Last checked: Nov 20, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

115

Actual

Start

Dec 2015

Primary completion

Jun 3, 2020

Study completion May 29, 2024

Sponsor

Lead sponsor
Phoenix KineticsNot on our public-company list
Sponsor type
Industry
First posted
Jun 29, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 30 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The NUsurface® Meniscus Implant SUN Clinical Trial is a multi-center, single-arm, prospective, open label, non-randomized, observational clinical trial to gather safety and probable clinical benefit data on the NUsurface® Meniscus Implant in treated the target population.

Conditions

  • Post-Meniscectomy Pain Syndrome
  • Osteoarthritis, Knee

Interventions

  • NUsurface® Meniscus ImplantDevice

    The NUsurface® Meniscus Implant is a Polycarbonate-Urethane (PCU)-based device reinforced with high tensile Ultra High Molecular Weight Polyethylene (UHMWPE) fibers. The product is available in different sizes, left and right, and with trials so as to allow the surgeon several size options for implantation. The NUsurface® Meniscus Implant, is designed to be conceptually analogous to the natural meniscus whose structural characteristics include a highly orientated collagen fiber network that supports the large hoop stresses to produce better distribution of contact pressures within the knee joint. Restoring the distribution of joint loads post-meniscectomy is thought to reducing joint overload and to reducing pain.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety assessed by Serious and non-serious, device-related and non-device related adverse eventsTime frame: 2 years
  2. Clinical PerformanceTime frame: 2 years

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Banner University Medical Center Phoenix

    Phoenix, Arizona

  • Horizon Clinical Research

    La Mesa, California

  • Long Beach Memorial Medical Center

    Long Beach, California

10 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.